These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1901 related items for PubMed ID: 17854872

  • 21. Histopathologic score predicts recurrence free survival after radical surgery in patients with stage IA2-IB1-2 cervical carcinoma.
    Grisaru DA, Covens A, Franssen E, Chapman W, Shaw P, Colgan T, Murphy J, DePetrillo D, Lickrish G, Laframboise S, Rosen B.
    Cancer; 2003 Apr 15; 97(8):1904-8. PubMed ID: 12673716
    [Abstract] [Full Text] [Related]

  • 22. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy.
    Liu MT, Hsu JC, Liu WS, Wang AY, Huang WT, Chang TH, Pi CP, Huang CY, Huang CC, Chou PH, Chen TH.
    Eur J Cancer Care (Engl); 2008 Mar 15; 17(2):174-81. PubMed ID: 18302655
    [Abstract] [Full Text] [Related]

  • 23. Pathologic stage I-II endometrial carcinoma in the elderly: radiotherapy indications and outcome.
    Citron JR, Sutton H, Yamada SD, Mehta N, Mundt AJ.
    Int J Radiat Oncol Biol Phys; 2004 Aug 01; 59(5):1432-8. PubMed ID: 15275729
    [Abstract] [Full Text] [Related]

  • 24. Prognostic factors in surgically treated stage ib-iib cervical carcinomas with special emphasis on the importance of tumor volume.
    Trattner M, Graf AH, Lax S, Forstner R, Dandachi N, Haas J, Pickel H, Reich O, Staudach A, Winter R.
    Gynecol Oncol; 2001 Jul 01; 82(1):11-6. PubMed ID: 11426955
    [Abstract] [Full Text] [Related]

  • 25. [Multivariate analysis of histopathologic prognostic factors in invasive cervical carcinoma treated with radical hysterectomy including paraaortic lymphadenectomy].
    Takeda N.
    Hokkaido Igaku Zasshi; 2003 Jan 01; 78(1):67-74. PubMed ID: 12613025
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy.
    Huang YT, Wang CC, Tsai CS, Lai CH, Chang TC, Chou HH, Lee SP, Hong JH.
    Int J Radiat Oncol Biol Phys; 2012 Oct 01; 84(2):420-7. PubMed ID: 22365621
    [Abstract] [Full Text] [Related]

  • 30. Oncologic outcome of fertility-sparing radical trachelectomy versus radical hysterectomy for stage IB1 cervical carcinoma.
    Diaz JP, Sonoda Y, Leitao MM, Zivanovic O, Brown CL, Chi DS, Barakat RR, Abu-Rustum NR.
    Gynecol Oncol; 2008 Nov 01; 111(2):255-60. PubMed ID: 18755500
    [Abstract] [Full Text] [Related]

  • 31. A comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervix.
    Nakanishi T, Ishikawa H, Suzuki Y, Inoue T, Nakamura S, Kuzuya K.
    Gynecol Oncol; 2000 Nov 01; 79(2):289-93. PubMed ID: 11063659
    [Abstract] [Full Text] [Related]

  • 32. Laparoscopic radical hysterectomy with lymphadenectomy in patients with early cervical cancer: our instruments and technique.
    Malzoni M, Tinelli R, Cosentino F, Perone C, Iuzzolino D, Rasile M, Tinelli A.
    Surg Oncol; 2009 Dec 01; 18(4):289-97. PubMed ID: 18805001
    [Abstract] [Full Text] [Related]

  • 33. Radical hysterectomy and pelvic lymphadenectomy for stage IB2 cervical cancer.
    Havrilesky LJ, Leath CA, Huh W, Calingaert B, Bentley RC, Soper JT, Alvarez Secord A.
    Gynecol Oncol; 2004 May 01; 93(2):429-34. PubMed ID: 15099957
    [Abstract] [Full Text] [Related]

  • 34. [Prognostic factors of stage IB and IIA carcinoma of the cervix treated by surgery].
    Zhang WH, Wu LY, Bai P, Li SM, Zhang R, Li B, Sun JH, Wu AR.
    Zhonghua Zhong Liu Za Zhi; 2004 Aug 01; 26(8):490-2. PubMed ID: 15555341
    [Abstract] [Full Text] [Related]

  • 35. Clinical significance of lympho vascular space involvement and lymph node micrometastases in early-stage cervical cancer: a retrospective case-control surgico-pathological study.
    Marchiolé P, Buénerd A, Benchaib M, Nezhat K, Dargent D, Mathevet P.
    Gynecol Oncol; 2005 Jun 01; 97(3):727-32. PubMed ID: 15943983
    [Abstract] [Full Text] [Related]

  • 36. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
    Jolly S, Vargas CE, Kumar T, Weiner SA, Brabbins DS, Chen PY, Floyd W, Martinez AA.
    Gynecol Oncol; 2006 Oct 01; 103(1):87-93. PubMed ID: 16545441
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
    Gadducci A, Cosio S, Fanucchi A, Cristofani R, Genazzani AR.
    Anticancer Res; 2000 Oct 01; 20(3B):1977-84. PubMed ID: 10928137
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Histopathological factors influencing pelvic lymph node metastases in two or more sites in patients with cervical carcinoma undergoing radical hysterectomy.
    Kamura T, Shigematsu T, Kaku T, Shimamoto T, Saito T, Sakai K, Mitsumoto M, Nakano H.
    Acta Obstet Gynecol Scand; 1999 May 01; 78(5):452-7. PubMed ID: 10326894
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 96.